The government has again raised the public activities restrictions (PPKM) status in Jakarta to Level 2, which will remain in effect from Tuesday (November 30, 2021) till Monday (December 13, 2021). The decision of raising the PPKM status in the capital city has been stipulated in the Instruction of the
The National Research and Innovation Agency (BRIN) will continue to focus on health research and innovation activities for the handling and mitigation of COVID-19, BRIN Head Laksana Tri Handoko has said. “At this time, BRIN still centers its focus on health research related to handling COVID-19, because, as we know, this pandemic
4th approved indication for toripalimab SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab in combination with cisplatin and
SAN DIEGO and BASEL, Switzerland, Nov. 29, 2021 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune disease, today announced that it has appointed Jacob Chacko, M.D., as Chair of its Board of Directors. Dr. Chacko currently serves as President, CEO